Travelan to progress to Phase 3 Clinical Trials in the US
Filed with ASX · · 6 pages · English
Earlier from Immuron
- Immuron achieves record Travelan sales
- Immuron achieves record half yearly Travelan sales
- First Patients Enrolled in Campylobacter Clinical Study
- Immuron achieves record quarterly Travelan sales
- Immuron achieves record monthly Travelan sales
Later from Immuron
- Immuron Travelan sales continued strong growth
- IMM-529 pre-IND FDA filing
- Immuron Travelan record sales globally, Australia and USA
- Appendix 4E and Preliminary Final Report
- Immuron Plans Phase 2 Trial for IMM-529 following FDA review
Follow Immuron into a list and get an email when it puts out news.
Follow Immuron